Oppose Elimination of GLP-1 (Anti-Obesity Medications) Coverage in Medi-Cal for Low-Income Californians

 

Starting June 12, adults on Medi-Cal may lose access to GLP-1 medications, a critical evidence-based treatment for obesity. This is a serious step backward for health equity in California.

 

The National Consumers League has urged state leaders to preserve access to these medications. But your voice is essential to make sure they listen. Sign our petition now to tell Governor Newsom and the California Legislature to protect access to obesity care and uphold the Obesity Bill of Rights.